• General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis

Article

Del-Ray, DUSA announce launch of 2009 Levulan PDT patient support kit

Johnson City, Tenn. ? Del-Ray Dermatologicals and DUSA Pharmaceuticals have entered into an agreement to include Blue Lizard Australian Sunscreen, moisturizer samples and Blue Lizard product coupons in the 2009 Levulan patient support kit, according to a company press release.

Johnson City, Tenn.

- Del-Ray Dermatologicals and DUSA Pharmaceuticals have entered into an agreement to include Blue Lizard Australian Sunscreen, moisturizer samples and Blue Lizard product coupons in the 2009 Levulan patient support kit, according to a company press release.

DUSA is expected to distribute more than 50,000 kits to dermatology offices in 2009, with the goal of educating dermatologists and their photodynamic therapy (PDT) patients on the photoprotection properties of their products.

The support kit contains educational materials about PDT treatment, a sun protective hat, Blue Lizard Sensitive samples, Blue Lizard Moisturizing Face samples and a coupon, among other things, according to the company.

Related Videos
E. James Song is featured in this video series.
E. James Song is featured in this video series.
Benjamin Lockshin, MD, FAAD, is featured in this series.
Benjamin Lockshin, MD, FAAD, is featured in this series.
Benjamin Lockshin, MD, FAAD, is featured in this series.
1 KOL is featured in this series.
2 KOLs are featured in this series.
1 KOL is featured in this series.
2 KOLs are featured in this series.
E. James Song is featured in this video series.
© 2024 MJH Life Sciences

All rights reserved.